Convatec is a Reading-based medical device manufacturer specializing in ostomy care, continence and infusion therapies, and wound care.
Is this your business? Add your evidence →
Convatec has achieved credible operational carbon reductions (62% Scope 1+2 by 2024) backed by SBTi validation, but Scope 3—representing 94% of footprint—targets intensity, not absolute cuts. Water and biodiversity impacts are identified but unquantified. Transparency is strong; controversies absent.
Convatec scores 39/100 (Below expectations) on SINK's independent climate assessment, scored from public data only. Fees pay for the review, never the result. Last verified August 2026.
That places Convatec joint 385th of 847 companies scored, and joint 11th of 19 in Healthcare / Pharmaceuticals.
Where Convatec sits among healthcare / pharmaceuticals peers.
Among the 19 major healthcare / pharmaceuticals brands we've scored, Convatec is tied =11th of 19, with 3 others.
Its three lowest-scoring questions, and what the evidence didn't show.
No formal biodiversity assessment, TNFD-aligned disclosure, deforestation commitment, or third-party verification found.
No quantified water consumption, withdrawal volumes, intensity metrics, or reduction targets surfaced.
Scope 3 target is intensity-based (52% per sold product by 2030), not absolute reduction.
A score changes when the evidence does. We use new published evidence at the next rescore. Evidence that isn't public can count through an evidence review.
Use this score in tenders
Send the link, or the one-page score sheet. It links back to this page and every source. Free.
Open the score sheet →Add your evidence, £99
Scored low because little is published? Send us your evidence. A person reviews it and your score reflects what you really do. Done within 5 working days.
Evidence review →Go tender-ready, £495 a year
A yearly rescore, a check of up to 25 key suppliers and a score badge for your website (coming soon).
Get in touch →Strongest on Controversies & Red Flags and Carbon Footprint — Operations (8/10, 7/10). Weakest on Nature & Biodiversity Impact and Water Impact (4/10, 4/10).
The 3 companies in the sector scoring nearest above Convatec.
AbbVie has achieved meaningful absolute emissions reductions and maintains science-aligned near-term climate targets, but obscures its full supply chain footprint and lacks net-zero validation.
See the breakdown →Philips demonstrates strong climate governance with SBTi-validated targets, 80% renewable energy, and A-list CDP scores across 11 years.
See the breakdown →The formula and all 10 sources.
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × Scale10 sources used in this assessment. All publicly available. Each row shows which of the ten questions it informed.
“In 2024, we reduced our Scope 1 and 2 GHG emissions by 14% against our 2023 emissions”
“2024 Independent assurance report PDF · ESG Basis of reporting FY24 PDF”
“In 2024, we reached 62% reduction against the baseline, achieved through improved energy efficiency, retrofits, smart metering”
“screening exercise during 2022 to determine which of the Scope 3 categories are most significant”
“Science Based Target, which was validated in 2023”
“B-rating from the Carbon Disclosure Project (CDP) and a Silver award from EcoVadis in their 2024 ratings”
“reducing Scope 1 and 2 greenhouse gas emissions by 6.9% and procuring over 99% of its electricity from renewable sources globally”
“The SBTi's Target Dashboard lists companies and financial institutions that have set science-based targets, or have committed to developing targets.”
“the majority of industrial companies in sectors like retail and healthcare not strategically involved in climate policy”
“In 2023, ConvaTec was included in the 'Leave Russia' project, which tracks companies that remain active in the Russian market”
If you believe a source has been misread or a newer version exists, submit a challenge.
Convatec is a Reading-based medical device manufacturer specializing in ostomy care, continence and infusion therapies, and wound care. Founded 1978, listed on NASDAQ. Operates global manufacturing and distribution networks serving healthcare systems and patients across 100+ countries.
One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
No spam. Unsubscribe in one click.
Checking a company?
Search free →Asked to prove you're sustainable?
Get your business scored, free →Been scored?
See what's behind your number →Fees pay for the review, never the result.